We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
+10.78%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$2.02B
AUM Growth
+$279M
Cap. Flow
+$128M
Cap. Flow %
6.33%
Top 10 Hldgs %
36.3%
Holding
443
New
14
Increased
200
Reduced
61
Closed
14

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$24M
2
MS icon
Morgan Stanley
MS
+$23.8M
3
HOLX
Hologic
HOLX
+$22.7M
4
SIVB
SVB Financial Group
SIVB
+$21.7M
5
MASI
Masimo
MASI
+$20.9M

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$26.1M
2
CNC icon
Centene
CNC
+$22.5M
3
GS icon
Goldman Sachs
GS
+$19.4M
4
EHC icon
Encompass Health
EHC
+$18.5M
5
C icon
Citigroup
C
+$16.4M

Sector Composition

Rank Sector Weight
1 Technology 27.26%
2 Healthcare 15.69%
3 Financials 14.89%
4 Consumer Discretionary 14.21%
5 Communication Services 12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
76
Abbott
ABT
$188B
$4.22M 0.21%
38,766
-2,300
-6% -$233K
TAL icon
77
TAL Education Group
TAL
$6.93B
$4.01M 0.2%
52,700
-6,000
-10% -$452K
AMD icon
78
Advanced Micro Devices
AMD
$767B
$3.95M 0.2%
48,212
+3,000
+7% +$223K
FIS icon
79
Fidelity National Information Services
FIS
$21.9B
$3.8M 0.19%
25,800
+1,700
+7% +$246K
INTU icon
80
Intuit
INTU
$91.5B
$3.45M 0.17%
10,584
+400
+4% +$125K
ABBV icon
81
AbbVie
ABBV
$438B
$3.39M 0.17%
38,707
-2,300
-6% -$217K
EDU icon
82
New Oriental
EDU
$9.24B
$3.21M 0.16%
21,500
– –
GILD icon
83
Gilead Sciences
GILD
$165B
$3.2M 0.16%
50,700
+1,900
+4% +$132K
TGT icon
84
Target
TGT
$69B
$3.16M 0.16%
20,100
+600
+3% +$82.3K
CVS icon
85
CVS Health
CVS
$122B
$3.11M 0.15%
53,325
+5,100
+11% +$317K
BMY icon
86
Bristol-Myers Squibb
BMY
$132B
$2.98M 0.15%
49,500
-35,900
-42% -$2.16M
VRTX icon
87
Vertex Pharmaceuticals
VRTX
$133B
$2.94M 0.15%
10,800
+800
+8% +$221K
YUMC icon
88
Yum China
YUMC
$16.5B
$2.93M 0.15%
55,400
– –
ITUB icon
89
Itaú Unibanco
ITUB
$86.9B
$2.93M 0.14%
1,010,495
– –
AXP icon
90
American Express
AXP
$229B
$2.92M 0.14%
29,100
+2,100
+8% +$207K
BKNG icon
91
Booking.com
BKNG
$160B
$2.91M 0.14%
42,500
+20,000
+89% +$1.4M
DE icon
92
Deere & Co
DE
$164B
$2.85M 0.14%
12,858
+1,500
+13% +$290K
TJX icon
93
TJX Companies
TJX
$175B
$2.78M 0.14%
49,900
+3,500
+8% +$189K
ELV icon
94
Elevance Health
ELV
$86.2B
$2.71M 0.13%
10,100
+400
+4% +$108K
APD icon
95
Air Products & Chemicals
APD
$68.6B
$2.71M 0.13%
9,100
+700
+8% +$201K
PDD icon
96
Pinduoduo
PDD
$132B
$2.7M 0.13%
36,400
– –
ATVI
97
DELISTED
Activision Blizzard
ATVI
$2.64M 0.13%
32,600
+2,100
+7% +$170K
CI icon
98
Cigna
CI
$73.6B
$2.61M 0.13%
15,415
+1,100
+8% +$194K
CSX icon
99
CSX Corp
CSX
$92.8B
$2.6M 0.13%
100,518
+12,000
+14% +$296K
FDX icon
100
FedEx
FDX
$76.9B
$2.59M 0.13%
10,300
+500
+5% +$100K
2 3
4
5 6

Similar funds

IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
CIC
Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return
SLI
Sumitomo Life Insurance Tokyo, Japan $4.25B AUM 23.69% 1-Year Est. Return

E. Ohman J:or Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, E. Ohman J:or Asset Management held 443 positions worth $2.02B, up 16% from $1.74B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

E. Ohman J:or Asset Management deployed $128M of net new capital in Q3 2020, opening 14 new positions and adding to 200 existing holdings. Its largest new stake was Masimo: 93,350 shares worth $22M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $26.1M trimmed.

  • E. Ohman J:or Asset Management's largest Q3 2020 buy was Masimo: 93,350 shares worth $22M.
  • E. Ohman J:or Asset Management added most to Ciena in Q3 2020, an estimated $24M increase.
  • E. Ohman J:or Asset Management's biggest Q3 2020 reduction was BioMarin Pharmaceuticals, cutting an estimated $26.1M.
  • E. Ohman J:or Asset Management fully exited Goldman Sachs in Q3 2020, selling an estimated $19.4M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 36% of its $2.02B portfolio in Q3 2020.
  • E. Ohman J:or Asset Management opened 14 new positions and closed 14 in Q3 2020.
  • E. Ohman J:or Asset Management's portfolio value rose 16% quarter-over-quarter to $2.02B.

Based on E. Ohman J:or Asset Management's 13F filing for Q3 2020, filed 5 Apr 2024.